Skip to main content
OpenTrials
Completed

NCT Number: NCT05168449

The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients

The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Kidney Diseases Adherence, Medication Behavior Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Health Behavior Kidney Diseases Male Urogenital Diseases Medication Adherence Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Compliance Renal Insufficiency Renal Insufficiency, Chronic Treatment Adherence and Compliance Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Private Clinic

Cairo, Egypt

About this study

This is a prospective randomized two group pharmacist-led interventional study that will be conducted in a private nephrology clinic. The study will involve introduction of the mobile phone applications to chronic kidney disease patients to improve their adherence to the prescribed medications.

Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured.

Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months.

The study will include the development, validation and the testing for evaluating the specially designed mobile application.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stages 2-5 of chronic kidney disease
  • Literate
  • Ownership of android smart phone compatible with the application
  • Poly-pharmacy

Exclusion criteria

  • On dialysis due to loss of kidney function
  • Pregnancy due to altered physiology

Treatment and study plan

Mobile application

Other

mobile phone applications directed to chronic kidney disease patients to improve their medication.

Primary outcomes

  1. Change in medication adherence

    Time frame: Change from baseline at 3 months

    Using a medication adherence questionnaire.

Secondary outcomes

  1. Change in estimated glomerular filtration rate/ creatinine clearance

    Time frame: Change from baseline at 3 months

    Calculated using serum creatinine lab results obtained from clinic.

  2. Change in systolic and diastolic blood pressure

    Time frame: Change from baseline at 3 months

    To be measured in clinic.

  3. Change in HbA1c

    Time frame: Change from baseline at 3 months

    Lab results obtained from clinic.

  4. Change in mobile application usability and acceptability by patients

    Time frame: Change from baseline at 3 months

    Using System Usability Scale (SUS) questionnaire. (scale 0-100 with higher score meaning better usability)

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

The Impact of Pharmacist - Led Mobile Application on Medication Adherence and Efficacy in Chronic Kidney Disease Patients

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Dec 23, 2021
Registry last updated
Feb 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.